Smithfield Trust CO Abbott Laboratories Transaction History

Smithfield Trust CO

$2.24 Billion
Q3 2025

A detailed history of Smithfield Trust CO transactions in Abbott Laboratories stock. As of the latest transaction made, Smithfield Trust CO holds 30,509 shares of ABT stock, worth $3.97 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares

30,509

Previous 30,573 0.21%

Holding current value

$3.97 Million

Previous $4.15 Million 1.64%

% of portfolio

0.18%

Previous 0.2%

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 07, 2025	SELL	$120.51 - $136.62 $7,712 - $8,743	-64 Reduced 0.21%	30,509 $4.09 Million
Q2 2025 Aug 08, 2025	SELL	$123.95 - $138.08 $53,050 - $59,098	-428 Reduced 1.38%	30,573 $4.15 Million
Q1 2025 May 09, 2025	BUY	$111.1 - $140.22 $3,666 - $4,627	33 Added 0.11%	31,001 $4.12 Million
Q3 2024 Nov 12, 2024	BUY	$100.07 - $118.13 $3,302 - $3,898	33 Added 0.11%	30,968 $3.53 Million
Q2 2024 Jul 31, 2024	SELL	$100.73 - $112.44 $5,842 - $6,521	-58 Reduced 0.19%	30,935 $3.21 Million

Q1 2024 May 07, 2024	SELL	$109.52 - $120.96 $43,698 - $48,263	-399 Reduced 1.27%	30,993 $3.52 Million
Q4 2023 Feb 07, 2024	SELL	$90.19 - $110.4 $13,438 - $16,449	-149 Reduced 0.47%	31,392 $3.46 Million
Q3 2023 Nov 06, 2023	SELL	$95.53 - $114.62 $172,813 - $207,347	-1,809 Reduced 5.42%	31,541 $3.05 Million
Q2 2023 Aug 08, 2023	BUY	$100.78 - $112.29 $15,217 - $16,955	151 Added 0.45%	33,350 $3.63 Million
Q1 2023 May 11, 2023	BUY	$96.86 - $114.01 $74,001 - $87,103	764 Added 2.36%	33,199 $3.36 Million
Q4 2022 Feb 13, 2023	BUY	$95.06 - $111.52 $6,464 - $7,583	68 Added 0.21%	32,435 $3.56 Million
Q3 2022 Nov 14, 2022	SELL	$96.76 - $112.03 $19,932 - $23,078	-206 Reduced 0.63%	32,367 $3.13 Million
Q2 2022 Aug 11, 2022	BUY	$102.07 - $123.37 $2,449 - $2,960	24 Added 0.07%	32,573 $3.53 Million
Q1 2022 May 16, 2022	SELL	$114.02 - $139.04 $82,094 - $100,108	-720 Reduced 2.16%	32,549 $3.85 Million
Q4 2021 Feb 14, 2022	SELL	$115.53 - $141.46 $24,376 - $29,848	-211 Reduced 0.63%	33,269 $4.68 Million
Q3 2021 Nov 12, 2021	BUY	$116.66 - $129.06 $108,027 - $119,509	926 Added 2.84%	33,480 $3.96 Million
Q2 2021 Jul 26, 2021	SELL	$105.79 - $124.53 $184,709 - $217,429	-1,746 Reduced 5.09%	32,554 $3.77 Million
Q1 2021 May 14, 2021	SELL	$108.84 - $128.23 $21,114 - $24,876	-194 Reduced 0.56%	34,300 $4.11 Million
Q4 2020 Feb 12, 2021	BUY	$105.0 - $114.42 $17,325 - $18,879	165 Added 0.48%	34,494 $3.78 Million
Q3 2020 Nov 16, 2020	BUY	$91.64 - $111.29 $11,913 - $14,467	130 Added 0.38%	34,329 $3.74 Million
Q2 2020 Aug 14, 2020	BUY	$76.57 - $98.0 $239,740 - $306,838	3,131 Added 10.08%	34,199 $3.13 Million
Q1 2020 May 05, 2020	SELL	$62.82 - $91.86 $29,651 - $43,357	-472 Reduced 1.5%	31,068 $2.45 Million
Q4 2019 Feb 13, 2020	SELL	$78.51 - $87.4 $44,907 - $49,992	-572 Reduced 1.78%	31,540 $2.74 Million
Q3 2019 Oct 30, 2019	SELL	$81.84 - $88.74 $11,866 - $12,867	-145 Reduced 0.45%	32,112 $2.69 Million
Q2 2019 Aug 06, 2019	BUY	$72.88 - $85.0 $12,972 - $15,130	178 Added 0.55%	32,257 $2.71 Million
Q1 2019 Apr 30, 2019	SELL	$66.22 - $80.06 $58,604 - $70,853	-885 Reduced 2.68%	32,079 $2.56 Million
Q4 2018 Feb 04, 2019	SELL	$65.56 - $74.27 $19,668 - $22,281	-300 Reduced 0.9%	32,964 $2.39 Million
Q3 2018 Nov 05, 2018	SELL	$60.81 - $73.36 $17,026 - $20,540	-280 Reduced 0.83%	33,264 $2.44 Million
Q2 2018 Jul 16, 2018	BUY	$57.57 - $63.54 $484,221 - $534,434	8,411 Added 33.47%	33,544 $2.05 Million
Q1 2018 May 10, 2018	SELL	$56.27 - $63.62 $92,958 - $105,100	-1,652 Reduced 6.17%	25,133 $1.51 Million
Q4 2017 Feb 02, 2018	BUY	$53.68 - $57.47 $623,171 - $667,169	11,609 Added 76.5%	26,785 $1.53 Million
Q3 2017 Nov 03, 2017	BUY	$48.06 - $53.64 $729,358 - $814,040	15,176	15,176 $810,000

Others Institutions Holding ABT

# of Institutions

3,651

Shares Held

1.38B

Call Options Held

10.4M

Put Options Held

9.01M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $228B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Smithfield Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Smithfield Trust CO with notifications on news.

Account

Smithfield Trust CO Abbott Laboratories Transaction History